Journal of Virology · 2019 · 15 citations · 35 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsMolecular VirologyVirologyAntiviral ImmunityGlycan-protein InteractionsHost-virus InteractionsViral Immune EvasionViral PathogenesisVirus-host InteractionsNeutralizing Antibody ProductionNeutralizing Antibody ResponsesViral Entry ReceptorsViral Envelope GlycoproteinsViral Evasion MechanismsViral Immune ResponsesViral Receptor Binding DomainsViral Spike Proteins
family, like Lassa and Junín viruses, are notorious human pathogens, which may lead to fatal outcomes when they infect people. It is thus important to develop means to combat these viruses. For developing effective vaccines, it is vital to understand the basic mechanisms that these viruses utilize in order to evade or overcome host immune responses. It was previously noted that the GP1 receptor-binding domain from Lassa virus is shed and accumulates in the serum of infected individuals. This raised the possibility that Lassa virus GP1 may function as an immunological decoy. Here we demonstrate that mice develop nonproductive immune responses against GP1 from Lassa virus, which is in contrast to the effective neutralizing responses that GP1 from Junín virus elicits. Thus, GP1 from Lassa virus is indeed an immunological decoy and GP1 from Junín virus may serve as a constituent of a future vaccine.
35
NIH Image to ImageJ: 25 years of image analysis
Caroline A Schneider, Wayne Rasband, Kevin W. Eliceiri · Nature Methods · 2012 · 65.2K citations
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou, Ivelin S. Georgiev, Xueling Wu et al. · Science · 2010 · 1.2K citations